Health ❯ Vaccines

Infectious Diseases

Respiratory Viruses Hantavirus AI in Medicine Lyme Disease Whooping Cough Mpox Vaccine Development Yellow Fever Avian Influenza Vaccine Technology Malaria Vaccine Research

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

The purchases mark a strategic shift into vaccine-led prevention that Lilly says will move forward only after routine regulatory clearances.

Moderna Jumps on Hantavirus Cruise-Ship Cluster as U.S. Repatriates 17 Citizens

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform